Probing of HIV-1 integrase/DNA interactions using novel analogs of viral DNA

被引:36
作者
Agapkina, J
Smolov, M
Barbe, S
Zubin, E
Zatsepin, T
Deprez, E
Le Bret, M
Mouscadet, JF
Gottikh, M
机构
[1] Ecole Normale Super, CNRS, LBPA, UMR8113, F-94235 Cachan, France
[2] Moscow MV Lomonosov State Univ, Belozersky Inst Physiochem Biol, Moscow 119992, Russia
关键词
D O I
10.1074/jbc.M512271200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The specific activity of the human immunodeficiency virus, type 1 ( HIV-1), integrase on the viral long terminal repeat requires the binding of the enzyme to certain sequences located in the U3 and U5 regions at the ends of viral DNA, but the determinants of this specific DNA-protein recognition are not yet completely understood. We synthesized DNA duplexes mimicking the U5 region and containing either 2'-modified nucleosides or 1,3-propanediol insertions and studied their interactions with HIV-1 integrase, using Mn2+ or Mg2+ ions as integrase cofactors. These DNA modifications had no strong effect on integrase binding to the substrate analogs but significantly affected 3'-end processing rate. The effects of nucleoside modifications at positions 5, 6, and especially 3 strongly depended on the cationic cofactor used. These effects were much more pronounced in the presence of Mg2+ than in the presence of Mn2+. Modifications of base pairs 7-9 affected 3'-end processing equally in the presence of both ions. Adenine from the 3rd bp is thought to form at least two hydrogen bonds with integrase that are crucial for specific DNA recognition. The complementary base, thymine, is not important for integrase activity. For other positions, our results suggest that integrase recognizes a fine structure of the sugar-phosphate backbone rather than heterocyclic bases. Integrase interactions with the unprocessed strand at positions 5-8 are more important than interactions with the processed strand for specific substrate recognition. Based on our results, we suggest a model for integrase interaction with the U5 substrate.
引用
收藏
页码:11530 / 11540
页数:11
相关论文
共 51 条
[1]   HIV-1 integrase can process a 3′-end crosslinked substrate -: Implications of DNA end-fraying requirement during the 3′-processing reaction [J].
Agapkina, J ;
Smolov, M ;
Zubin, E ;
Mouscadet, JF ;
Gottikh, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (01) :205-211
[2]   Structural determinants of metal-induced conformational changes in HIV-1 integrase [J].
Asante-Appiah, E ;
Seeholzer, SH ;
Skalka, AM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (52) :35078-35087
[3]   A metal-induced conformational change and activation of HIV-1 integrase [J].
AsanteAppiah, E ;
Skalka, AM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) :16196-16205
[4]   OLIGONUCLEOTIDE DUPLEXES CONTAINING 2'-AMINO-2'-DEOXYCYTIDINES - THERMAL-STABILITY AND CHEMICAL-REACTIVITY [J].
AURUP, H ;
TUSCHL, T ;
BENSELER, F ;
LUDWIG, J ;
ECKSTEIN, F .
NUCLEIC ACIDS RESEARCH, 1994, 22 (01) :20-24
[5]   The use of diaminopurine to investigate structural properties of nucleic acids and molecular recognition between ligands and DNA [J].
Bailly, C ;
Waring, MJ .
NUCLEIC ACIDS RESEARCH, 1998, 26 (19) :4309-4314
[6]   Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides [J].
Brodin, P ;
Pinskaya, M ;
Buckle, M ;
Parsch, U ;
Romanova, E ;
Engels, J ;
Gottikh, M ;
Mouscadet, JF .
BIOCHEMISTRY, 2002, 41 (05) :1529-1538
[7]   Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat ends [J].
Chen, AP ;
Weber, IT ;
Harrison, RW ;
Leis, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (07) :4173-4182
[8]   Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: A model for viral DNA binding [J].
Chen, JCH ;
Krucinski, J ;
Miercke, LJW ;
Finer-Moore, JS ;
Tang, AH ;
Leavitt, AD ;
Stroud, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (15) :8233-8238
[9]   Mechanism of HIV-1 integrase inhibition by styrylquinoline derivatives in vitro [J].
Deprez, E ;
Barbe, S ;
Kolaski, M ;
Leh, H ;
Zouhiri, F ;
Auclair, C ;
Brochon, JC ;
Le Bret, M ;
Mouscadet, JF .
MOLECULAR PHARMACOLOGY, 2004, 65 (01) :85-98
[10]  
Dickerson RE, 1997, BIOPOLYMERS, V44, P361, DOI 10.1002/(SICI)1097-0282(1997)44:4<361::AID-BIP4>3.0.CO